Aurion Biotech, Inc. (AURN)

Aurion Biotech Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	3.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	55.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$9,522
Profits Per Employee	-$868,377
Employee Count	69
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Aurion Biotech has paid $42,000 in taxes.

Income Tax	42,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aurion Biotech had revenue of $657,000 and -$59.92 million in losses.

Revenue	657,000
Gross Profit	-997,000
Operating Income	-60.37M
Pretax Income	-59.88M
Net Income	-59.92M
EBITDA	-60.28M
EBIT	-60.98M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $52.07 million in cash and $62.55 million in debt, giving a net cash position of -$10.49 million.

Cash & Cash Equivalents	52.07M
Total Debt	62.55M
Net Cash	-10.49M
Net Cash Per Share	n/a
Equity (Book Value)	-220.54M
Book Value Per Share	n/a
Working Capital	39.67M

Cash Flow

In the last 12 months, operating cash flow was -$51.88 million and capital expenditures -$786,000, giving a free cash flow of -$52.67 million.

Operating Cash Flow	-51.88M
Capital Expenditures	-786,000
Free Cash Flow	-52.67M
FCF Per Share	n/a

Margins

Gross margin is -151.75%, with operating and profit margins of -9,189.19% and -9,119.94%.

Gross Margin	-151.75%
Operating Margin	-9,189.19%
Pretax Margin	-9,113.55%
Profit Margin	-9,119.94%
EBITDA Margin	-9,174.28%
EBIT Margin	-9,280.82%
FCF Margin	-8,016.59%

Dividends & Yields

Aurion Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a